| Followers | 3 |
| Posts | 222 |
| Boards Moderated | 0 |
| Alias Born | 02/23/2024 |
Thursday, February 29, 2024 5:39:54 AM
AACR is the number 1 cancer congress , it will only accept abstracts of clinical trials that where not published or presented yet. They want to be the first to present breaking new cancer research. To ensure this, they embargoe all clinical abstracts until the start of the congress. The companies who wants to present there, may not publish any results before the AACR congres. This would immediately explain why we are waiting sooo long for ONTARGET results.
Second, Crofelemer was allready presented at AACR in 2020, by Jaguar Health offcourse, but for CID in Dogs. So why would AACR not be interested to present Phase 3 clinical trial in humans.
!! Go to the website of AACR, you will see that the online publication of the program (and abstracts) is on March 5th. Next tuesday. Only after or on that data, companies that were accepted to present, may PR that they will present there.
Recent JAGX News
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/13/2026 08:59:50 PM
- Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing • GlobeNewswire Inc. • 03/13/2026 12:35:00 PM
- Jaguar Health Presenting March 12 at the Life Sciences Virtual Investor Forum to Provide Updates on Near-Term Catalysts • ACCESS Newswire • 03/11/2026 01:00:00 PM
- Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th • GlobeNewswire Inc. • 03/10/2026 02:21:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/09/2026 01:05:16 PM
- Jaguar Health Strengthens Company's Balance Sheet by Restructuring and Reducing Royalty and Debt Obligations and Extinguishing Warrants • ACCESS Newswire • 03/09/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2026 09:15:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/03/2026 02:05:51 PM
- Jaguar Health Secures an Additional $3 Million Payment from Future Pak for Mytesi and Canalevia-CA1 • ACCESS Newswire • 03/03/2026 02:00:00 PM
- Reminder: Today, March 2, 2026, is the Record Date for Jaguar Health's Special One-time Stock Dividend • ACCESS Newswire • 03/02/2026 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/18/2026 02:01:37 PM
- Jaguar Health Announces a Special One-time Stock Dividend • ACCESS Newswire • 02/18/2026 02:00:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/10/2026 07:12:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2026 09:15:29 PM
- Jaguar Health Highlights Sharp Strategic Focus on Rare Intestinal Failure Diseases Fueled by Non-Dilutive Funds from Closing of License Deal for Mytesi • ACCESS Newswire • 01/22/2026 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/21/2026 09:30:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/21/2026 09:30:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:05:24 PM
- Jaguar Health Presenting January 15 at Lytham Partners Healthcare Investor Summit to Provide Updates on Near-Term Catalysts • ACCESS Newswire • 01/14/2026 02:00:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/12/2026 06:05:58 PM
- Jaguar Health Enters into U.S. License Agreement with Future Pak for Crofelemer, Providing up to $38 Million • ACCESS Newswire • 01/12/2026 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2026 11:04:18 AM
- Article About Groundbreaking Results from Study of Jaguar Health's Crofelemer for Treatment of Intestinal Failure Featured in United Arab Emirates Healthcare Publication • ACCESS Newswire • 01/06/2026 02:00:00 PM
- Jaguar Health Awarded $240,000 FDA Grant in Support of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs • ACCESS Newswire • 01/02/2026 02:00:00 PM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
